[1] |
Liu Lili, Yuan Yuting, Lai Gengliang, Tian Chuan, Lan Xiang, Ye Zhonglv.
The relationship between minimal residual disease on day 15 and prognosis in children with acute lymphoblastic leukemia
[J]. Clinical Focus, 2024, 39(1): 47-52.
|
[2] |
.
[J]. Clinical Focus, 2023, 38(10): 954-960.
|
[3] |
Dong Zhengrong, Tao Qianshan, Shen Yuanyuan, Dong Yi.
Analysis of the follow-up results of 163 patients with acute promyelocytic leukemia
[J]. Clinical Focus, 2023, 38(9): 813-818.
|
[4] |
Du Jiayi, Liu Lili, He Yongzhong, Tian Chuan, Lan Xiang, Ye Zhonglyu.
Clinical observation of serious adverse events in children with acute lymphoblastic leukemia during chemotherapy
[J]. Clinical Focus, 2023, 38(2): 149-154.
|
[5] |
Yin Lingling, Wu Wenjian, Zhu Feng.
Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia: A case report and literature review
[J]. Clinical Focus, 2022, 37(11): 1025-1030.
|
[6] |
Shen Ziyuan, Kang Haiquan, Sang Wei, Yan Dongmei.
Analysis of bacterial distribution, resistance and risk factor of death of bacterial infection in leukemia patients
[J]. Clinical Focus, 2021, 36(12): 1092-1096.
|
[7] |
Ma Rui, Sun Yuqian.
Standardized treatment of acute leukemia by haplo-identical stem cell transplantation
[J]. Clinical Focus, 2021, 36(10): 869-873.
|
[8] |
Lu Wenyi, Zhao Mingfeng.
The standard treatment of acute lymphoblastic leukemia
[J]. Clinical Focus, 2021, 36(10): 874-879.
|
[9] |
Liu Qiaoxue, Wei Hui.
Standardized treatment of acute myeloid leukemia
[J]. Clinical Focus, 2021, 36(10): 880-883.
|
[10] |
Qin Yazhen.
Standardized detection of BCR-ABL mRNA and clinical application in patients with chronic myeloid leukemia
[J]. Clinical Focus, 2021, 36(10): 884-888.
|
[11] |
Wang Hui, Chen Man.
Flow cytometry in minimal residual disease detection of acute myeloid leukemia: current status and progress
[J]. Clinical Focus, 2021, 36(10): 889-895.
|
[12] |
Liu Jianning, Sun Li, Niu Zhiyun, Wen Shupeng, Wang Ying, Zhang Xuejun, Wang Fuxu.
Expression of PD-1 on T-lymphocytes in acute leukemia after allogeneic hematopoietic stem cell transplantation
[J]. Clinical Focus, 2021, 36(3): 251-255.
|
[13] |
.
[J]. Clinical Focus, 2021, 36(2): 188-192.
|
[14] |
Ren Jinhai;Guo Xiaoling;Cai Shengxin.
Diagnosis and treatment of relapsed/refractory acute myeloid leukemia
[J]. Clinical Focus, 2015, 30(10): 1100-1103.
|
[15] |
Guo Xiaonan;Qiao Shukai.
Standardized management of tyrosine kinase inhibitors therapy for patients with chronic myelogenous leukemia in clinic
[J]. Clinical Focus, 2015, 30(10): 1104-1109.
|